Accelerate Clinical Validation, Potency & Funding of Off-the-Shelf Therapies with Innovations in Engineering, Analytics & Scalable Delivery to Maximize Access in Oncology & Beyond

This Event has now run. Thank You to our Speakers, Sponsors, and Delegates who joined us in Boston for the Summit!

Driving Potency, Efficacy & Durability of Universal Cell Therapies

The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as reduced cost, production and patient accessibility compared to its autologous counterparts.

Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th Annual Allogeneic Cell Therapies Summit returned to Boston in June as the leading industry focused meeting dedicated to accelerating the safety, durability and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.

Across a jam-packed agenda consisting of 60+ hours of content and 3 in-depth tracks, 50+ expert speakers led you discussions to help to transform universal cell therapies for patients across the globe.

Pre-Clinical Track

Clinical Track

Manufacturing & Process Development Track


Hours of Content


In-Depth Tracks


Expert Speakers




New Speaking Companies



View the 2024 Agenda

Brochure front cover ss

2024 World Class Speaker Faculty Included:

Bryan Kobel Speaker

Bryan Kobel

Chief Executive Officer & Board Director

TCBiopharm New!

Colleen Delaney Speaker

Colleen Delaney

Founder and Chief Scientific Officer, EVP of Research and Development

Deverra Therapeutics

Erin Kimbrel Speaker

Erin Kimbrel

Vice President of Research

Astellas New!

Paul Song Speaker

Paul Song

Chief Executive Officer

NKGen Biotech New!

"The networking opportunities are great. I get the chance to talk to many people in this field and get to know some key players. Talks are relevant and informative”

Stemcell Technologies

Who Attended in 2024?

41314 - Allo - Previously Attending Companies - Logo cloud (2)

"Was great to meet Chief Scientific Officers and other high-level management from multiple companies”

Poseida Therapeutics

2024 Partners:

Lead Partner

41314 - Allo - Partner Logos

Program Partners

CareDx - Allogeneic Cell Therapies Summit
Allo 2024 Partner logo - Corning
Rapid Micro Biosystems - Allogeneic Cell Therapies Summit

Hosting Partners

Innovation Partners

41314 - Allo - Partner Logos (2)
Allo 2024 Partner logo - Roslin
Accelerated Biosciences - Allogeneic Cell Therapies Summit

Exhibition Partners

Event Partners

41314 - Allo - Partner Logos (1)
BioIVT - Allogeneic Cell Therapies Summit
41314 - Allo - Partner Logos (3)
Miltenyi - Allogeneic Cell Therapies Summit
Cellbri (2)
Allo 2024 Partner logo - WellSky